Pre-Inspection Readiness
Master Compliance with our Mock Inspections for Your Seamless Pre-inspection Readiness
Master Compliance with our Mock Inspections for Your Seamless Pre-inspection Readiness
The pharmaceutical manufacturing industry requires rigorous audit and inspection readiness to ensure compliance with quality standards. These inspections are crucial for ensuring the quality and safety of pharmaceutical products. Therefore, pharmaceutical companies must approach these inspections with careful planning, attention to detail, and a proactive mind-set.
Zenovel acknowledges the demanding and time-consuming nature of preparing for audit and inspection. Our team of professionals offers comprehensive simulated inspection services to help prepare your facility for US-FDA, EMA, and MHRA inspection. We conducts audit or mock inspection, review your documentations and quality systems, validate your process, and provide valuable feedback on areas for improvement.
To effectively prepare, first acquaint yourself with the inspection procedure. The following phases are involved:
The FDA field inspector’s conducts inspection at facilities, reviewing records, interviewing personnel, and assessing compliance with regulations.
The FDA releases an inspection report outlining any observations or conclusions.
The FDA informs pharmaceutical company of an upcoming inspection, which can be given as little as five days or weeks in advance, even sometimes a surprised visit happens
Pharmaceutical company should conduct a comprehensive self-assessment, evaluate all SOP’s and regulatory documentation, and thoroughly examine processes to ensure easy accessibility of all relevant material.
To pass an FDA inspection, a proactive, risk-based strategy is necessary for effective quality system, process, and regulatory adherence, requiring crucial preparatory actions.
The implementation of internal mock inspections can identify readiness gaps, familiarize staff with the inspection procedure, and offer practical experience in handling inquiries. Our mock inspection readiness services offers simulate real inspection scenarios, reviewing processes, quality management system, documentation, and compliance levels. We identify gaps and provide targeted recommendations, ensuring your team is well-prepared for regulatory audits, reducing non-compliance risks, and enhancing inspection outcomes.
The European Union’s Good Manufacturing Practice (GMP) standards, as outlined in the Annex to the Guide to Good Manufacturing Practice for Medicinal Products, ensure the quality and safety of medicinal products, including those used in clinical trials. The Qualified Person (QP) plays a crucial role in batch certification, particularly for
In the intricate process of developing new pharmaceuticals, guaranteeing product safety, effectiveness, and adherence to global regulations is essential. Batch release testing acts as a pivotal quality assurance measure, confirming that medications comply with rigorous criteria before distribution. When combined with International Council for Harmonisation (ICH) standards, this testing framework
In the world of life sciences, quality isn’t just a benchmark—it’s the backbone of success. Three key pillars—Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP)—form the core framework that supports everything from product development to regulatory approval. These standards aren’t just industry buzzwords; they’re the
In the pharmaceutical industry, quality is paramount—and at Zenovel, we are deeply committed to delivering excellence in Quality Assurance (QA). Our focus is on ensuring that every medicine is developed, manufactured, and delivered with safety and reliability as top priorities. QA is embedded in every stage of the pharmaceutical lifecycle—from
The U.S. Food and Drug Administration (FDA) emphasize the importance of data integrity in pharmaceutical manufacturing, particularly under its Current Good Manufacturing Practices (CGMP) rules. However, issues like fake lab results and sloppy record-keeping persist, posing risks to patients and losing confidence in the system. Independent oversight is crucial to
In the rapidly evolving pharmaceutical industry, assuring product quality and customer safety is a need. This endeavour continues to be based on validation, a methodical procedure to verify that manufacturing procedures and equipment consistently deliver high-quality outcomes. A strong strategy to validation is required in 2025 due to the complexity
